Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: The existing risk prediction models for COVID-19 associated mortality have not considered the difference in risk factors in patients across an aging population. AIM: To develop age-specific prediction models to forecast the risk of all-cause mortality in patients recovering from COVID-19 infection. DESIGN: Population-based, retrospective cohort study. METHODS: Patients with COVID-19 between 1 April 2020 and 31 July 2022 survived beyond the acute phase of infection were stratified into separate age cohorts (<45, 45-64, ≥65) and followed-up for one year. Backward stepwise logistic regression and four statistical and machine learning algorithms were employed to develop age-specific models on the risk of post-acute mortality following COVID-19 infection, based on a comprehensive set of clinical parameters including demographics, COVID-19 vaccination status, pre-existing comorbidities and laboratory-test findings. RESULTS: Of the 891,246 patients with COVID-19 identified, 13,578 (1.05%) died within one year of the index date. Age, COVID-19 vaccination status and history of acute respiratory syndrome prior infection were identified as predictors in the models for separate age groups. The model for patients aged ≥65 exhibited excellent prediction performance with an AUROC of 0.87 (95% CI: 0.87, 0.88), followed by the model for patients aged 45-64 [AUROC=0.83 (95% CI: 0.81, 0.85)] and those aged <45 [AUROC=0.79 (95% CI: 0.72, 0.86)]. CONCLUSION: The age-specific models reported accurately predicted the risk of post-acute mortality in their corresponding age-group of patients, providing valuable asset in optimising clinical strategies and resource allocation in the management of the global burden of Long COVID.

More information Original publication

DOI

10.1093/qjmed/hcaf218

Type

Journal article

Publication Date

2025-09-22T00:00:00+00:00

Keywords

All-cause mortality, COVID-19, Machine-learning, Post-acute sequelae of SARS-CoV-2, Prediction modelling, SARS-CoV-2 infection